Nantahala Capital Management’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,692
Closed -$50.4K 122
2024
Q1
$50.4K Hold
26,692
﹤0.01% 107
2023
Q4
$70.5K Sell
26,692
-68
-0.3% -$180 ﹤0.01% 107
2023
Q3
$61.5K Hold
26,760
0.01% 108
2023
Q2
$97.7K Sell
26,760
-66,537
-71% -$243K 0.01% 102
2023
Q1
$333K Hold
93,297
0.03% 97
2022
Q4
$266K Hold
93,297
0.02% 91
2022
Q3
$208K Sell
93,297
-7,167
-7% -$16K 0.01% 90
2022
Q2
$250K Sell
100,464
-2,143,895
-96% -$5.33M 0.01% 92
2022
Q1
$11M Sell
2,244,359
-295,341
-12% -$1.44M 0.48% 30
2021
Q4
$28.7M Sell
2,539,700
-31,382
-1% -$355K 1.01% 18
2021
Q3
$37.5M Sell
2,571,082
-106,584
-4% -$1.55M 1.18% 14
2021
Q2
$31.2M Sell
2,677,666
-26,317
-1% -$307K 0.89% 17
2021
Q1
$33M Buy
2,703,983
+197,211
+8% +$2.41M 0.96% 18
2020
Q4
$31.4M Buy
2,506,772
+164,556
+7% +$2.06M 0.97% 20
2020
Q3
$35.3M Buy
2,342,216
+16,828
+0.7% +$253K 1.08% 11
2020
Q2
$57M Sell
2,325,388
-178,452
-7% -$4.37M 1.72% 5
2020
Q1
$35.5M Buy
2,503,840
+1,098,899
+78% +$15.6M 1.33% 11
2019
Q4
$22.3M Buy
1,404,941
+26,743
+2% +$425K 0.69% 24
2019
Q3
$11.6M Hold
1,378,198
0.43% 34
2019
Q2
$12.4M Buy
1,378,198
+500,100
+57% +$4.5M 0.38% 38
2019
Q1
$6.79M Hold
878,098
0.21% 52
2018
Q4
$4.13M Buy
878,098
+25,000
+3% +$117K 0.13% 62
2018
Q3
$7.72M Buy
853,098
+429,518
+101% +$3.89M 0.21% 44
2018
Q2
$5.02M Buy
+423,580
New +$5.02M 0.2% 46